Surgical Recovery After Left Lateral Hepatic Sectionectomy: Laparoscopic Versus Open Surgery.

NCT00874224 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2016-03-09

No results posted yet for this study

Summary

The ORANGE II trial is a double blinded randomised controlled trial that will provide evidence on the merits of laparoscopic surgery in patients undergoing a left lateral hepatic sectionectomy in terms of time to functional recovery, hospital length of stay, quality of life, readmission percentage, morbidity and mortality, hospital costs, body image and cosmesis, and long term incidence of incisional hernias.

Conditions

Interventions

PROCEDURE

laparoscopic left lateral hepatic sectionectomy

laparoscopic left lateral hepatic sectionectomy

PROCEDURE

open left lateral hepatic sectionectomy

open left lateral hepatic sectionectomy

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER
  • UMC Utrecht

    collaborator OTHER
  • Medisch Spectrum Twente

    collaborator OTHER
  • University Medical Center Groningen

    collaborator OTHER
  • Erasmus Medical Center

    collaborator OTHER
  • University Medical Center Nijmegen

    collaborator OTHER
  • Onze Lieve Vrouwe Gasthuis

    collaborator OTHER
  • Maxima Medical Center

    collaborator OTHER
  • Isala

    collaborator OTHER
  • San Raffaele University Hospital, Italy

    collaborator OTHER
  • University Hospital, Aachen

    collaborator OTHER
  • Deventer Ziekenhuis

    collaborator OTHER
  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Ronald M van Dam, MD · Maastricht University Medical Centre

  • Cornelis HC Dejong, MD, PhD · Maastricht University Medical Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00874224 on ClinicalTrials.gov